| # | Drug | Count |
|---|---|---|
| 0 | ASPIRIN | 62 |
| 1 | ASPIRIN 81 MG | 62 |
| 2 | ASPIRIN 325 MG | 61 |
| 3 | RIVAROXABAN | 56 |
| 4 | VALSARTAN | 35 |
| 5 | ADALIMUMAB | 30 |
| 6 | DABIGATRAN ETEXILATE | 29 |
| 7 | DABIGATRAN ETEXILATE MESYLATE | 28 |
| 8 | CLOPIDOGREL | 27 |
| 9 | SIMVASTATIN | 26 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ACYCLOVIR AND HYDROCORTISONE | 1 | 0.0250 |
| 1 | MEDICATED HEMORRHOIDAL WIPES | 2 | 0.0230 |
| 2 | MARSTACIMAB-HNCQ | 1 | 0.0097 |
| 3 | ANDEXANET ALFA | 5 | 0.0071 |
| 4 | ASPIRIN AND DIPYRIDAMOLE | 1 | 0.0041 |
| 5 | BROMPHENIRAMINE MALEATE, DEXTROMETHORPHAN HYDROBROMIDE | 1 | 0.0031 |
| 6 | BROMPHENIRAMINE MALEATE | 1 | 0.0028 |
| 7 | DIPHENHYDRAMINE HYDROCHLORIDE AND PHENYLEPHRINE HYDROCHLORIDE | 1 | 0.0028 |
| 8 | BENAZEPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE | 1 | 0.0022 |
| 9 | DESOGESTREL/ETHINYL ESTRADIOL AND ETHINYL ESTRADIOL | 1 | 0.0019 |
| # | Drug class | Count |
|---|---|---|
| 0 | Nonsteroidal Anti-inflammatory Drug [EPC] | 85 |
| 1 | Factor Xa Inhibitor [EPC] | 83 |
| 2 | Platelet Aggregation Inhibitor [EPC] | 65 |
| 3 | Corticosteroid [EPC] | 45 |
| 4 | Angiotensin 2 Receptor Blocker [EPC] | 43 |
| 5 | HMG-CoA Reductase Inhibitor [EPC] | 34 |
| 6 | Proton Pump Inhibitor [EPC] | 34 |
| 7 | Vitamin C [EPC] | 31 |
| 8 | Insulin Analog [EPC] | 28 |
| 9 | beta-Adrenergic Blocker [EPC] | 27 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Vasopressin Receptor Agonist [EPC] | 1 | 0.0030 |
| 1 | Endoglycosidase [EPC] | 2 | 0.0011 |
| 2 | Adrenal Steroid Synthesis Inhibitor [EPC] | 1 | 0.0010 |
| 3 | Humanized Monoclonal Antibody Fragment [EPC] | 1 | 0.0007 |
| 4 | Guanylate Cyclase-C Agonist [EPC] | 1 | 0.0005 |
| 5 | alpha-1 Adrenergic Agonist [EPC] | 2 | 0.0005 |
| 6 | Provitamin D2 Compound [EPC] | 13 | 0.0004 |
| 7 | Human Immunoglobulin G [EPC] | 9 | 0.0004 |
| 8 | Thrombopoietin Receptor Agonist [EPC] | 6 | 0.0004 |
| 9 | Factor Xa Inhibitor [EPC] | 83 | 0.0003 |